Larvol Delta - BlossomHill-Therapeutics-Announces-Upcoming-Poster-Presentation-on-Phase-12-SOLARA-Trial-of-BH30643-a-Firstinclass-Macrocyclic-OMNIEGFR-Inhibitor-at-the-AACRNCIEORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics

BH-30643 - BlossomHill Therap

https://www.globenewswire.com/news-release/2025/10/14/3166039/0/en/BlossomHill-Therapeutics-Announces-Upcoming-Poster-Presentation-on-Phase-1-2-SOLARA-Trial-of-BH-30643-a-First-in-class-Macrocyclic-OMNI-EGFR-Inhibitor-at-the-AACR-NCI-EORTC-Interna.html

Oct 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next